⌘K

Home/Filings/4/0001193125-25-227233

4//SEC Filing

Brainard Diana 4

Accession 0001193125-25-227233

CIK 0000906709other

View on SEC.gov Company Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 7:50 PM ET

Size

5.3 KB

Accession

0001193125-25-227233

Insider Transaction Report

Form 4

Period: 2025-09-30

NEKTAR THERAPEUTICSNKTR

Director

Transactions

Award
Stock Option
2025-09-30+8,000→ 8,000 total
Exercise: $56.90Exp: 2033-09-29→ Common Stock (8,000 underlying)

Footnotes (1)

[F1]This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1

filerCIK 0001818070

Filing Metadata

Form type: 4
Filed: Sep 30, 8:00 PM ET
Accepted: Oct 1, 7:50 PM ET
Size: 5.3 KB

View on SEC.gov